title: The phenotype and genotype of rheumatoid arthritis in the Democratic Republic of Congo.
abstract: BACKGROUND
  Little is known about rheumatoid arthritis in the black, particularly in Congolese, populations. Our objective was to describe the phenotype and genotype of rheumatoid arthritis (RA) in Congolese.
  
  
  METHODS
  All consecutive rheumatoid arthritis (RA) patients attending Kinshasa University Hospital in a three-year time period were included. Demographics, clinical features and tobacco consumption were noted. Disease Activity Score (DAS)-28 based on the erythrocyte sedimentation rate (ESR), Health Assessment Questionnaire (HAQ), anti-citrullinated peptide antibodies (CCP) antibodies and rheumatoid factor (RF) were determined. Radiographs were scored according to Sharp-van der Heijde. On a subset of patients and controls HLA-DRB1 typing was performed.
  
  
  RESULTS
  A total of 114 females and 14 males aged 51.2 ± 14.9 were included. Mean duration of symptoms was four years. Moderate tobacco consumption was reported in a minority of patients. DAS-28 at first visit was >5.1 and HAQ ≥0.5 in all patients. X-rays showed joint erosions and/or joint space narrowing, mostly of a moderate grade in 55.8% of patients. Anti-CCP and/or RF were present in 48.6% of patients with available data (n = 72) and in 3.0% of controls (n = 67). Radiographic changes and nodules were more frequent in RF or anti-CCP positive patients. One copy of the shared epitope was found in 13 patients (35.1%) and 3 controls (12.5%). Two copies were found in one patient (2.7%) and in one control (4.2%).
  
  
  CONCLUSIONS
  Congolese patients with RA consult long after disease onset. Despite this delay, the majority presents without major damage and is RF, anti-CCP and SE negative. We put forward the hypothesis that besides different environmental factors there is probably also a particular genetic risk profile in Congolese patients, different from the HLA-DRB1 shared epitope.
authors: J J
authors: JJ
authors: Malemba
authors: J M
authors: JM
authors: Mbuyi-Muamba
authors: J
authors: J
authors: Mukaya
authors: X
authors: X
authors: Bossuyt
authors: M P
authors: MP
authors: Emonds
authors: K
authors: K
authors: Deiteren
authors: R
authors: R
authors: Westhovens
authors: P
authors: P
authors: Verschueren
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001172:Arthritis, Rheumatoid / Q000235:genetics* / Q000276:immunology / Q000473:pathology*; D001323:Autoantibodies / Q000097:blood; D001324:Autoantigens / Q000276:immunology; D015023:Democratic Republic of the Congo; D005260:Female; D005838:Genotype; D059811:HLA-DRB1 Chains / Q000235:genetics*; D006801:Humans; D007118:Immunoassay; D008297:Male; D008875:Middle Aged; D010641:Phenotype; D016133:Polymerase Chain Reaction; D012217:Rheumatoid Factor / Q000097:blood; D055815:Young Adult
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D059811:HLA-DRB1 Chains; D012217:Rheumatoid Factor
references: Tissue Antigens. 2003 May;61(5):403-7
references: 12753660
references: Rheumatology (Oxford). 2009 Sep;48(9):1111-3
references: 19581382
references: Arthritis Rheum. 2010 Feb;62(2):369-77
references: 20112396
references: Autoimmun Rev. 2007 Jun;6(6):402-8
references: 17537386
references: Ann Rheum Dis. 1986 Aug;45(8):691-5
references: 3740998
references: Clin Rheumatol. 2005 Nov;24(6):615-9
references: 15895197
references: Arthritis Res Ther. 2010;12(2):R36
references: 20196860
references: Hum Immunol. 1999 Feb;60(2):152-8
references: 10027783
references: Semin Arthritis Rheum. 2001 Dec;31(3):191-8
references: 11740799
references: Curr Opin Rheumatol. 2010 May;22(3):293-8
references: 20061955
references: Rev Rhum Mal Osteoartic. 1991 Jun;58(6):459-65
references: 1896787
references: Lancet. 1968 Aug 17;2(7564):380-2
references: 4174413
references: Ann Rheum Dis. 2007 Jan;66(1):59-64
references: 16901955
references: Arthritis Rheum. 2005 Sep;52(9):2637-44
references: 16142711
references: Arthritis Res Ther. 2012 Apr 26;14(2):R89
references: 22537824
references: Rheumatology (Oxford). 2000 Jan;39(1):28-33
references: 10662870
references: Tissue Antigens. 2000 Jan;55(1):48-52
references: 10703608
references: Clin Exp Rheumatol. 2008 Jul-Aug;26(4):673-9
references: 18799105
references: Clin Rheumatol. 2008 Jan;27(1):47-54
references: 17541812
references: J Rheumatol. 2001 Jul;28(7):1486-91
references: 11469451
references: Clin Rheumatol. 2010 Jun;29(6):593-7
references: 20094746
references: J Rheumatol. 1999 Mar;26(3):743-5
references: 10090194
references: Rheumatology (Oxford). 2012 Sep;51(9):1644-7
references: 22627729
references: Clin Rheumatol. 1998;17(2):105-9
references: 9641505
references: Arthritis Res Ther. 2008;10(1):R26
references: 18307784
references: Arthritis Rheum. 2008 Feb;58(2):349-58
references: 18240241
references: Arthritis Rheum. 2005 Apr;52(4):1063-8
references: 15818663
references: Arthritis Res Ther. 2009;11(4):238
references: 19678909
references: Arthritis Rheum. 1988 Mar;31(3):315-24
references: 3358796
references: Rheumatology (Oxford). 2009 Oct;48(10):1309-13
references: 19696061
references: Clin Rheumatol. 2007 Feb;26(2):201-4
references: 16572283
references: Arthritis Rheum. 2009 Apr;60(4):924-30
references: 19333936
references: Hum Immunol. 2001 May;62(5):523-9
references: 11334677
references: Arthritis Rheum. 2001 Feb;44(2):307-14
references: 11229460
references: Arthritis Res Ther. 2011;13(5):R160
references: 21978430
references: Semin Arthritis Rheum. 2002 Jun;31(6):355-60
references: 12077707
references: Arthritis Rheum. 1995 Jan;38(1):44-8
references: 7818570
references: Ann Rheum Dis. 2006 Apr;65(4):453-8
references: 16176994
references: Ann Rheum Dis. 2010 Sep;69(9):1580-8
references: 20699241
references: Arthritis Rheum. 2005 Mar;52(3):722-32
references: 15751097
references: Rev Rhum Mal Osteoartic. 1991 Feb;58(2):105-11
references: 2042005
references: Arthritis Rheum. 2006 Jan;54(1):60-7
references: 16385496